openPR Logo

Press Releases from ORGANOBALANCE GmbH (7 total)

Increasing the Potential for Yeast Strains in Biotech Manufacturing

ORGANOBALANCE to present its latest research findings at ACHEMA 2012 Berlin, 13 June 2012 – At this year's ACHEMA (Frankfurt,18 to 22 June), the Berlin-based biotech company ORGANOBALANCE GmbH will present its most recent findings on the potential uses of yeast strains in the biotechnological production of fine chemicals and new ingredients for pharmaceuticals, cosmetics, foods or feedstuffs (metabolic engineering of yeasts). In his talk, The yeast Saccharomyces cerevisiae as platform organism

ORGANOBALANCE Signs Licensing Agreement with Sanofi Pasteur

Modified strain of yeast paves way for new industrial vaccine production process Berlin, 11 January 2012 – The company ORGANOBALANCE GmbH, Berlin, Germany, today announced the conclusion of a licensing agreement with Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY). This will provide Sanofi Pasteur with access to a modified yeast strain (Saccharomyces cerevisiae, more commonly known as baker's yeast) for use in vaccines. By signing the

Lonza and ORGANOBALANCE Enter Global License Agreement to Develop and Market Uni …

Basel, Switzerland and Berlin, Germany, 19 April 2011 – Lonza and ORGANOBALANCE today announced the signing of a worldwide exclusive license agreement in which Lonza will develop, produce and commercialize products containing a probiotic Lactobacillus strain. Developed by ORGANOBALANCE GmbH, the probiotic strain acts against Helicobacter pylori (H. pylori). Research shows that H. pylori has been implicated as a common cause of peptic ulcers and gastritis. Currently, about 50 percent of

ORGANOBALANCE to present latest research findings at the BIOTECHNICA Trade Show …

Berlin-based company to intensify efforts in contract research and white biotechnology Berlin, September 28, 2010 – Once again this year, ORGANOBALANCE will present current projects and latest research findings to an international audience of experts at the BIOTECHNICA Trade Show taking place in Hannover, Germany from October 5 to 7, 2010. Since 2001, the Berlin-based company has been doing research - primarily for clients from the fields of red, white and green

ORGANOBALANCE Announces Substantial Investment

Dr Bernd Wegener to invest in Berlin (Germany) Biotech company Berlin (Germany), 17 June 2010 – ORGANOBALANCE GmbH Berlin and Bernd Wegener DVM, PhD (Chairman of the Board of the German Federal Association of the Pharmaceutical Industry), have announced the completion of an investment agreement which shall take immediate effect. Aside from detailing a financial commitment, the agreement also foresees an active role for Dr Wegener in a position of responsibility

Chemel AB and ORGANOBALANCE GmbH start business cooperation in Germany

Lund, Sweden / Berlin, Germany, October 16, 2009 – At Biotechnica exhibition in Hannover, 6-8 October 2009, Chemel AB (publ) and ORGANOBALANCE GmbH agreed on a business cooperation of mutual benefit. ORGANOBALANCE is specializing in microbial strain development and microbiological screening. The company develops new biological products in the areas of nutrition, cosmetics, preventive health care, and industrial biotechnology, all based on specific probiotic cultures. In its development activities, the company

ORGANOBALANCE plans further partnerships in probiotics research

Berlin biotech company presents current projects at Biotechnica in Hannover Berlin, 02 October 2009 – From 06 to 08 October 2009 ORGANOBALANCE GmbH is presenting its current projects and research findings at Europe's largest gathering for the biotechnology industry. The Berlin-based company conducts research into probiotic lactic acid bacteria and yeasts and uses their positive properties for innovative products. Biotechnica provides the perfect environment for an exchange with science and industry

Go To Page:   1 2 3 4 5 6 7 8 9 10